Damasceno Junior, E.; Barbosa, R.d.M.; da Silva, R.d.C.D.; Costa, F.d.S.; da Silva, D.R.; Viseras, C.; Perioli, L.; Fernandes, N.S.
Montmorillonite–Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic. Pharmaceutics 2023, 15, 512.
https://doi.org/10.3390/pharmaceutics15020512
AMA Style
Damasceno Junior E, Barbosa RdM, da Silva RdCD, Costa FdS, da Silva DR, Viseras C, Perioli L, Fernandes NS.
Montmorillonite–Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic. Pharmaceutics. 2023; 15(2):512.
https://doi.org/10.3390/pharmaceutics15020512
Chicago/Turabian Style
Damasceno Junior, Elmar, Raquel de Melo Barbosa, Rita de Cássia Dantas da Silva, Felipe dos Santos Costa, Djalma Ribeiro da Silva, César Viseras, Luana Perioli, and Nedja Suely Fernandes.
2023. "Montmorillonite–Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic" Pharmaceutics 15, no. 2: 512.
https://doi.org/10.3390/pharmaceutics15020512
APA Style
Damasceno Junior, E., Barbosa, R. d. M., da Silva, R. d. C. D., Costa, F. d. S., da Silva, D. R., Viseras, C., Perioli, L., & Fernandes, N. S.
(2023). Montmorillonite–Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic. Pharmaceutics, 15(2), 512.
https://doi.org/10.3390/pharmaceutics15020512
